|
Name |
4-Hepten-3-one, 5-methyl-
|
| Molecular Formula | C8H14O | |
| IUPAC Name* |
(E)-5-methylhept-4-en-3-one
|
|
| SMILES |
CC/C(=C/C(=O)CC)/C
|
|
| InChI |
InChI=1S/C8H14O/c1-4-7(3)6-8(9)5-2/h6H,4-5H2,1-3H3/b7-6+
|
|
| InChIKey |
XJEHTASYOBAEDB-VOTSOKGWSA-N
|
|
| Synonyms |
4-Hepten-3-one, 5-methyl-; 1447-26-3; (E)-5-methylhept-4-en-3-one; (E)-5-Methyl-4-hepten-3-one; 20685-44-3; 5-methyl-4-hepten-3-one; 5-methylhept-4-en-3-one; 4-Hepten-3-one, 5-methyl-, (E)-; starbld0044620; 5-Methyl-4-hepten-3-on; 3-Methyl-3-hepten-5-one; (4E)-5-Methyl-4-hepten-3-one; (4E)-5-methylhept-4-en-3-one; ZINC96327924; (4E)-5-Methyl-4-hepten-3-one #
|
|
| CAS | 1447-26-3 | |
| PubChem CID | 5364923 | |
| ChEMBL ID | NA |
Chemical Classification: |
|
|
|---|
| Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
|---|---|---|---|---|---|---|---|---|
| Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
| Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
| Molecular Weight: | 126.2 | ALogp: | 2.3 |
| HBD: | 0 | HBA: | 1 |
| Rotatable Bonds: | 3 | Lipinski's rule of five: | Accepted |
| Polar Surface Area: | 17.1 | Aromatic Rings: | 0 |
| Heavy Atoms: | 9 | QED Weighted: | 0.531 |
| Caco-2 Permeability: | -4.39 | MDCK Permeability: | 0.00002720 |
| Pgp-inhibitor: | 0.015 | Pgp-substrate: | 0.02 |
| Human Intestinal Absorption (HIA): | 0.006 | 20% Bioavailability (F20%): | 0.859 |
| 30% Bioavailability (F30%): | 0.051 |
| Blood-Brain-Barrier Penetration (BBB): | 0.995 | Plasma Protein Binding (PPB): | 59.11% |
| Volume Distribution (VD): | 1.027 | Fu: | 39.50% |
| CYP1A2-inhibitor: | 0.291 | CYP1A2-substrate: | 0.172 |
| CYP2C19-inhibitor: | 0.108 | CYP2C19-substrate: | 0.713 |
| CYP2C9-inhibitor: | 0.027 | CYP2C9-substrate: | 0.529 |
| CYP2D6-inhibitor: | 0.013 | CYP2D6-substrate: | 0.343 |
| CYP3A4-inhibitor: | 0.02 | CYP3A4-substrate: | 0.249 |
| Clearance (CL): | 9.717 | Half-life (T1/2): | 0.895 |
| hERG Blockers: | 0.016 | Human Hepatotoxicity (H-HT): | 0.073 |
| Drug-inuced Liver Injury (DILI): | 0.497 | AMES Toxicity: | 0.034 |
| Rat Oral Acute Toxicity: | 0.034 | Maximum Recommended Daily Dose: | 0.027 |
| Skin Sensitization: | 0.896 | Carcinogencity: | 0.066 |
| Eye Corrosion: | 0.981 | Eye Irritation: | 0.988 |
| Respiratory Toxicity: | 0.655 |
| Similar NPs | Similar Drugs | ||||||
|---|---|---|---|---|---|---|---|
| NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
| ENC002251 | ![]() |
0.378 | D0ZK8H | ![]() |
0.265 | ||
| ENC000313 | ![]() |
0.333 | D0Q9HF | ![]() |
0.231 | ||
| ENC001203 | ![]() |
0.324 | D0Y3KG | ![]() |
0.225 | ||
| ENC000224 | ![]() |
0.323 | D0F1GS | ![]() |
0.212 | ||
| ENC001585 | ![]() |
0.314 | D0Z4NI | ![]() |
0.212 | ||
| ENC005107 | ![]() |
0.314 | D0G4JI | ![]() |
0.200 | ||
| ENC001556 | ![]() |
0.314 | D0U7BW | ![]() |
0.200 | ||
| ENC001734 | ![]() |
0.308 | D0XB8P | ![]() |
0.200 | ||
| ENC001735 | ![]() |
0.308 | D06RCB | ![]() |
0.196 | ||
| ENC000225 | ![]() |
0.303 | D0M1PQ | ![]() |
0.195 | ||